JP2021505241A5 - - Google Patents

Download PDF

Info

Publication number
JP2021505241A5
JP2021505241A5 JP2020530311A JP2020530311A JP2021505241A5 JP 2021505241 A5 JP2021505241 A5 JP 2021505241A5 JP 2020530311 A JP2020530311 A JP 2020530311A JP 2020530311 A JP2020530311 A JP 2020530311A JP 2021505241 A5 JP2021505241 A5 JP 2021505241A5
Authority
JP
Japan
Prior art keywords
days
patent document
international
prior
documents cited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020530311A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021505241A (ja
JP7296084B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/059579 external-priority patent/WO2019111132A1/en
Publication of JP2021505241A publication Critical patent/JP2021505241A/ja
Publication of JP2021505241A5 publication Critical patent/JP2021505241A5/ja
Application granted granted Critical
Publication of JP7296084B2 publication Critical patent/JP7296084B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020530311A 2017-12-04 2018-12-03 長時間作用型胃滞留システム Active JP7296084B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762594257P 2017-12-04 2017-12-04
US62/594,257 2017-12-04
US201862681525P 2018-06-06 2018-06-06
US62/681,525 2018-06-06
PCT/IB2018/059579 WO2019111132A1 (en) 2017-12-04 2018-12-03 Long acting gastric residence system

Publications (3)

Publication Number Publication Date
JP2021505241A JP2021505241A (ja) 2021-02-18
JP2021505241A5 true JP2021505241A5 (https=) 2021-11-18
JP7296084B2 JP7296084B2 (ja) 2023-06-22

Family

ID=64902152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020530311A Active JP7296084B2 (ja) 2017-12-04 2018-12-03 長時間作用型胃滞留システム

Country Status (4)

Country Link
US (2) US11547839B2 (https=)
EP (1) EP3720537B1 (https=)
JP (1) JP7296084B2 (https=)
WO (1) WO2019111132A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11576859B2 (en) 2015-10-23 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
WO2017100367A1 (en) 2015-12-08 2017-06-15 Lyndra, Inc. Geometric configurations for gastric residence systems
CN109310639A (zh) 2016-05-27 2019-02-05 林德拉有限公司 用于胃驻留系统的材料结构
JP2019532947A (ja) 2016-09-30 2019-11-14 リンドラ,インコーポレイティド アダマンタン系薬物の持続的送達のための胃内滞留システム
CA3066658A1 (en) 2017-06-09 2018-12-13 Lyndra, Inc. Gastric residence systems with release rate-modulating films
WO2019111132A1 (en) * 2017-12-04 2019-06-13 Clexio Biosciences Ltd. Long acting gastric residence system
US11511093B2 (en) 2019-10-11 2022-11-29 Wonkwang University Center for Industry Academy Cooperation Gastroretentive drug delivery device having expandable structure and manufacturing method therefor
EP4204064A1 (en) * 2020-08-30 2023-07-05 Teva Pharmaceutical Industries Ltd. Devices for regio-specific release of carried drug at ileocecal region
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions
CN115518052B (zh) * 2022-09-22 2024-01-02 江苏集萃新型药物制剂技术研究所有限公司 胃滞留制剂及其制备方法
AU2023366929A1 (en) 2022-10-25 2025-05-08 Veradermics, Incorporated Compositions and methods of use for modified release minoxidil

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1318259A (en) 1919-10-07 Resilient wheel
AU449029B2 (en) 1969-08-28 1974-04-17 Commonwealth Scientific And Industrial Research Organisation Device for administration to ruminants
US4220153A (en) 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
JPS6226215A (ja) 1985-05-10 1987-02-04 メルク エンド カムパニ− インコ−ポレ−テツド 一定に制御した時間内胃中に保持できる薬剤移送装置
US4735804A (en) 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
CA1273872A (en) 1985-05-10 1990-09-11 Larry J. Caldwell Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
JPH03163011A (ja) 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd 胃内滞留デバイス
IT1282650B1 (it) 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
IL133196A0 (en) 1999-11-29 2001-03-19 Yissum Res Dev Co Gastroretentive controlled release pharmaceutical dosage forms
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
DE60123384T2 (de) 2000-02-04 2007-08-02 DepoMed, Inc., Menlo Park Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
US6723340B2 (en) 2001-10-25 2004-04-20 Depomed, Inc. Optimal polymer mixtures for gastric retentive tablets
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20050202090A1 (en) 2002-01-03 2005-09-15 Clarke Allan J. Novel pharmaceutical dosage forms and method for producing same
GB0214013D0 (en) 2002-06-18 2002-07-31 Euro Celtique Sa Pharmaceutical product
US20050013863A1 (en) 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
IL166183A0 (en) 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
CA2613178A1 (en) 2005-07-15 2007-01-25 Kissei Pharmaceutical Co., Ltd. Sustained release preparation
US8187633B2 (en) 2005-11-03 2012-05-29 Sun Pharma Advanced Research Company Limited Controlled release coated tablets having prolonged gastric retention
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
EP2997953B1 (en) 2006-01-18 2018-12-26 Intec Pharma Ltd. Delivery device for oral intake of an agent
WO2007093999A1 (en) 2006-02-15 2007-08-23 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
WO2007106957A1 (en) 2006-03-21 2007-09-27 Laboratoires Smb S.A. Multiple units controlled-release floating dosage forms
US9579227B2 (en) 2006-03-29 2017-02-28 Eat Little Inc. Ingestible implement for weight control
CA2673485A1 (en) 2007-01-15 2008-07-24 Kissei Pharmaceutical Co., Ltd. Gastric retention-type sustained-release levodopa preparation
EP2219624A2 (en) 2007-11-08 2010-08-25 Glaxo Group Limited Pharmaceutical formulations
CN102149369B (zh) 2008-04-18 2016-08-10 因泰克制药有限公司 卡比多巴/左旋多巴胃滞留给药
EP2133071A1 (en) 2008-06-09 2009-12-16 Université de la Méditerranée Process for making gastroretentive dosage forms
JP2012500230A (ja) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
US20110268666A1 (en) 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
US20110066175A1 (en) 2009-05-07 2011-03-17 Rainbow Medical Ltd. Gastric anchor
EP2490677A2 (en) 2009-10-19 2012-08-29 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
WO2011090724A2 (en) 2009-12-29 2011-07-28 Impax Laboratories, Inc. Gastroretentive solid oral dosage forms with lipid-based low-density excipient
CN101919803A (zh) 2010-07-16 2010-12-22 钟术光 一种控释制剂
WO2012006963A1 (zh) 2010-07-16 2012-01-19 Zhong Shuguang 在控释制剂中的聚合物增强剂
US9941319B2 (en) 2010-10-13 2018-04-10 Monolithic 3D Inc. Semiconductor and optoelectronic methods and devices
WO2012059815A1 (en) 2010-11-01 2012-05-10 Intec Pharma Ltd. Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
US20130072869A1 (en) 2011-09-15 2013-03-21 The Johns Hopkins University Intra-Gastric Timed-Release Drug Delivery System
WO2013054285A1 (en) 2011-10-11 2013-04-18 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
KR101461332B1 (ko) 2013-08-02 2014-11-13 삼성전기주식회사 센서용 검출모듈 및 이를 구비하는 각속도 센서
US9016811B2 (en) 2013-08-05 2015-04-28 Concealment Solutions Inc. Apparatus for concealing household objects
EP3091962B1 (en) 2013-12-05 2022-06-08 Epitomee Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents
WO2015187746A1 (en) * 2014-06-02 2015-12-10 Teva Pharmaceutical Industries Ltd. Expandable gastroretentive dosage form
NZ727659A (en) 2014-06-11 2021-12-24 Massachusetts Inst Technology Residence structures and related methods
CA3007165A1 (en) 2015-12-02 2017-06-08 Clexio Biosciences Ltd. Device for preparing gastroretentive dosage forms
CN110035718B (zh) * 2016-12-02 2021-04-06 克雷西奥生物科技有限公司 胃内滞留系统
WO2019111132A1 (en) * 2017-12-04 2019-06-13 Clexio Biosciences Ltd. Long acting gastric residence system

Similar Documents

Publication Publication Date Title
JP2021505241A5 (https=)
JP2019502892A5 (https=)
JP2019536800A5 (https=)
JP2021524958A5 (https=)
JP2019514354A5 (https=)
JP2023021979A5 (https=)
JP2017206702A5 (https=)
JP2017514639A5 (https=)
CN112004801A (zh) 一种c-MET 抑制剂的晶型及其盐型和制备方法
JP2020531120A5 (https=)
JP2020531121A5 (https=)
MX2009012950A (es) ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS.
CN110198943A (zh) 作为Wee1抑制剂的1,2-二氢-3H-吡唑[3,4-d]嘧啶-3-酮衍生物
JP2014509874A5 (https=)
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
EP3005993A3 (en) Gastric bypass system and method
JP2020534246A5 (https=)
JP2022521336A5 (https=)
CY1120240T1 (el) Απο του στοματος χορηγουμενο παρασκευασμα δισκιου ενωσης τετρακυκλινης
JP2020512939A5 (https=)
JP2016527801A5 (https=)
JP2017505825A5 (https=)
JP2019218304A5 (https=)
CN110546261A (zh) 小rna及其用于预防和/或治疗纤维增生性病症和/或综合征
JP2023521031A5 (https=)